Penserra Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,509
Closed -$11K – 1001
2022
Q2
$11K Sell
2,509
-810
-24% -$5.85K ﹤0.01% 1223
2022
Q1
$28K Buy
3,319
+166
+5% +$1.17K ﹤0.01% 1157
2021
Q4
$27K Sell
3,153
-1,942
-38% -$18.5K ﹤0.01% 1182
2021
Q3
$52K Sell
5,095
-4,210
-45% -$36.8K ﹤0.01% 1040
2021
Q2
$97K Sell
9,305
-1,584
-15% -$15.6K ﹤0.01% 800
2021
Q1
$112K Buy
+10,889
New +$151K ﹤0.01% 670

Other funds holding SRTA

Penserra Capital Management's SRTA Position: Q3 2022 in Review

Penserra Capital Management sold out of Strata Critical Medical Inc (SRTA) in Q3 2022, closing a stake of 2,509 shares — an estimated $11K sold.

Penserra Capital Management first reported a position in SRTA in Q1 2021 and held it in 6 quarters. The position peaked at $112K in Q1 2021. 99 funds tracked by Wall St. Rank hold SRTA as of Q3 2022.

  • Penserra Capital Management reported no remaining Strata Critical Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 2,509 Strata Critical Medical Inc shares in Q3 2022, an estimated $11K.
  • Penserra Capital Management first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 6 quarters.
  • Penserra Capital Management's Strata Critical Medical Inc position peaked at $112K in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.